Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

200results about How to "Production economy" patented technology

Display correcting method and device for naked-eye stereo display equipment

The invention provides a display correcting method and a display correcting device for naked-eye stereo display equipment. The display correcting method comprises the following steps: acquiring a first predetermined image displayed by the naked-eye stereo display equipment according to preset image arrangement parameters; according to the first predetermined image, acquiring actual image attributes of the first predetermined image; according to the preset image arrangement parameters and the actual image attributes of the first predetermined image, acquiring first correcting parameters; storing the first correcting parameters, and performing naked-eye stereo display by the naked-eye stereo display equipment according to the first correcting parameters. An error appearing in the production process of a display device of the naked-eye stereo display equipment is detected, the correcting parameters are stored, and during the follow-up naked-eye stereo display, display is corrected according to the correcting parameters, so that the display equipment displays a standard image and a stereo display effect is ensured; the display correcting method provided by the invention is applicable to different display equipment; With the display correcting method, the correcting process is simplified and the design cost is saved.
Owner:SUPERD CO LTD

Preparation method of clobetasol and preparation method of clobetasol propionate

The invention discloses a preparation method of clobetasol and the preparation method of clobetasol propionate. The preparation method of the clobetasol comprises the following steps: by taking a compound I, namely 1,4,9(11)-triene androstane-3,17-diketone as an initial raw material, performing a methylation reaction, a cyan substitution reaction, a siloxy protection reaction, an intramolecular nucleophilic substitution reaction, a bromoepoxy reaction and a fluorination reaction to prepare a compound VII which is clobetasol. The compound VII is subjected to a propyl esterification reaction to prepare a compound VIII which is clobetasol propionate. According to the preparation method disclosed by the invention, since relatively basic initial raw materials which are cheap are used, each step of reaction is relatively easy to implement and high yield is achieved; the operation of multi-step protection and deprotection is simplified; moreover, 21 sites of fluorine are directly arranged in one step during arrangement of a side chain, and multiple steps of reaction for arranging the 21 sites of fluorine in the prior art are directly avoided, so that the synthetic route is greatly shortened, the total yield is increased, the product quality is improved and the production cost is greatly lowered.
Owner:江西赣亮医药原料有限公司

Medicine for curing non-alcoholic steatohepatitis and preparation method thereof

The invention provides medicine for curing non-alcoholic steatohepatitis and a preparation method thereof. The medicine is prepared from traditional Chinese medicine as raw materials, and the ingredients of the raw materials are mainly radix astragali, semen coicis, rhizoma alismatis, seaweed, dandelion, radix salviae miltiorrhizae, polygonum cuspidatum, hawthorn, radix bupleuri, folium nelumbinis and polygonum multiflorum. The medicine is prepared into a water-honeyed pill, namely a dampness-dispelling stasis-dispersing fat-fighting pill. The traditional Chinese medicine is selected according to three-method combination of clearing heat and dampness, activating blood and dissolving stasis, and soothing liver and strengthening spleen, and a prescription is formed according to a principle of dispelling dampness, removing stasis and strengthening spleen, so that the effects of removing fat, dropping enzyme and repairing damaged liver cells can be achieved. Animal acute toxicity tests and pharmacodynamic tests prove that the medicine has good safety, can obviously control blood fat and improve the fatty liver, and has an obvious effect of losing weight. The medicine is clinically applied, the basic cure rate is 57.5 percent, the total effective rate is 94.3 percent, and the curative effect is higher than that of national medicine 'simvastatin' approved by the state and the current medicine for curing the fatty liver in China.
Owner:邵阳县中医医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products